Aktis Oncology, Inc. is a clinical-stage biotechnology company dedicated to transforming the treatment of solid tumors through the development of targeted alpha-emitting radiopharmaceuticals. The company's innovative approach leverages its proprietary platform to create highly potent and selective radioligand therapies designed to deliver alpha radiation directly to cancer cells, minimizing damage to healthy tissues. Aktis Oncology's pipeline is focused on addressing significant unmet needs in oncology, particularly for patients with difficult-to-treat solid tumors. Their lead programs are engineered to target specific tumor antigens, ensuring precise delivery of therapeutic payloads. By utilizing alpha emitters, which have a short path length and high linear energy transfer, Aktis aims to achieve superior tumor killing efficacy compared to traditional beta-emitting radiopharmaceuticals. The company's strategy involves advancing its lead candidates through clinical development, while also expanding its platform to discover new targets and develop next-generation radiopharmaceuticals. Aktis Oncology is positioned within the rapidly evolving field of radiopharmaceutical therapy, seeking to establish itself as a leader in this promising modality for cancer treatment.
The sum of declared dividends issued by a company for every ordinary share outstanding.
Dividend Yield is a financial ratio that shows how much a company pays out in dividends each year relative to its share price in the last twelve months. In the absence of any capital gains, the dividend yield is the return on investment for a stock.
It is another way that companies have to remunerate their shareholders, being an alternative to dividends. Shows the % of repurchases per share made in the last 12 months in relation to the share price.
Sum of Dividend Yield and BuyBack Yield to show the total return that the shareholder received in the last 12 months in relation to the share price.
The dividend payout ratio is the ratio of the total amount of dividends paid out to shareholders relative to the net income of the company. It is the percentage of earnings paid to shareholders via dividends.
Retained earnings (RE) are the amount of net income left over for the business after it has paid out dividends to its shareholders and are an important variable for assessing a company's financial health because it shows the net income that a company has saved over time, and therefore has the ability to reinvest in the business or distribute to shareholders.
...and much more!